CURRICULUM VITAE PERSONAL DETAILS: RAHAL, MOHAMED
|
|
|
- Elijah Hubbard
- 5 years ago
- Views:
Transcription
1 PERSONAL DETAILS: CURRICULUM VITAE NAME: RAHAL, MOHAMED MARITAL STATUS: ADDRESS: Married, 3 children King Fahad Specialist Hospital Oncology Department PO BOX DAMMAM Kingdom of Saudi Arabia Tel: moharahal@hotmail.com CITIZENSHIP: Algerian American Green card holder LICENSE TO PRACTICE: Algeria 1979 France 1979 Saudi Arabia: 1995
2 HOSPITAL APPOINTMENTS: Fellow in Radiation /Oncology, Tenon Hospital, Paris, France Fellow in Radiation /Oncology, Institut Gustave Roussy, Paris, France Medical and Radiation Oncologist Staff Physician, Benbadis University Hospital, Constantine, Algeria Department Chairman, Oncology Department, Benbadis University Hospital, Constantine Medical Oncologist, King Faisal Specialist Hospital Riyadh Saudi Arabia: Oct 2005 Medical Oncologist, King Fahad Specialist Hospital Dammam Saudi Arabia: Nov Section Head Adult Medical Oncology KFSH-Dammam Jan April 2013 Deputy Chairman Medical Oncology KFSH-Dammam May 2013-Present BOARD CERTIFICATION: Algerian Board in Radiation Oncology, Algiers, Algeria 1980 Qualifying Certificate in Head and Neck Oncology, Paris, France 1982 French Board Radiation-Oncology, Strasbourg, France 1982 Qualifying Certificate in Stem Cell Transplantation, Vienna, Austria 1997 European Certification in Medical Oncology, Switzerland, 2006 European Recertification in Medical Oncology, Switzerland, 2011 POST SPECIALTY STUDIES: Qualifying Certificate in Head and Neck Oncology, Paris, France 1982
3 Qualifying certificate in Stem Cell Transplantation, Vienna, Austria 1997 Diploma in Neuro Endocrine Tumors, Uppsala, Sweden 2010 ASCO-ESMO Cancer Research Workshop, Alahsa, 2012 ESMO Preceptorship on Neuro Endocrine Tumors, Singapore 2014 ADVISORY BOARD: Aventis Middle East Advisory board in breast cancer, Paris Feb 2007 Renal Cell Carcinoma workshop Expert, Paris, France 2011 Aventis Colorectal Advisory Board, Riyadh Feb 2013 LANGUAGE: Arabic, French, English: Proficient in conversation, reading and writing. MEMBERSHIPS IN PROFESSIONAL AND SCIENTIFIC SOCIETIES: American Society of Clinical Oncology 1988 International Nasopharyngeal Cancer Study Group 1989 European Society of Medical Oncology 2001 American Academy of Hospice and Palliative Care 2008 Member of Rare Cancer Network 2010 European Neuro Endocrine Tumor Society : ENETS 2011
4 MANUSCRIPTS :2008-Onwards 1- M. Rahal, E.Hassan, S Shakir, A Meshikhes, H Ramadan,S. EL Hady, A.AlMulla, F.AlManaa,A.Abdewarith, A,Alfaraj. What is the optimal duration of FOLFOX-Bevacizumab in metastatic colorectal cancer (Mcrc)? 6 th international symposium on targeted anti cancer therapies. Bethesda, USA, March S. Akhtar, A.ElWeshi, M. Rahal,M.Abdelsalam, High dose chemotherapy and autologous stem cell transplant for relapsed or refractory Hodgkin's lymphoma in 58 adolescent patients. Evaluation of prognostic factors and their impact on survival. EBMT 2009, Abs, M. Rahal, A.Abdewarith, E.Hassan, S.Deo,H.Ramadan, N.AlNaimy. N.AlEissa.. HER - 2 positive locally advanced breast cancer one or two entities? ESMO 2009, Abs M.Rahal, H.Ramadan,E Hassan,A. Arini, H. Mosleh, A. Abdelwarith, E.Senan, N.Al Naimy, A.AlFaraj, H.Halawani. Neoadjuvant platinum containing regimen for locally advanced triple negative breast cancer. Ann Onc vol 21,Supp 8,114, M.Rahal, H.Abdullah,, H.Halawani, H.Zagloul, A. AlBuali, A.AlFaraj, E Hassan, H.Abdulkhalek, A Ahluwalia, F.Medhat. Plasma EBV-DNA concentration correlates with FDG-EBV in nasopharyngeal cancer treated with induction chemotherapy.ann Onc 1028, 2012, 23 ( suppl 9)
5 RESEARCH PROTOCOLS : 1. Bazarbashi S, Rahal M, Manji M, Isbester W. A pilot trial of preoperative chemoradiotherapy using Capecitabine (Xeloda) and external beam radiation followed by definitive surgery in patients with localized (non-metastatic rectal cancer). 2. Ezzat A, Rahal M. Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer. 3. Bazarbashi S, Raja M, Rahal M. Phase II trial of concurrent administration of intravesical BCG and interferon α-2b in the treatment and prevention of recurrence of superficial TCC of the urinary bladder. 4. M.Rahal, S Akhtar,S Bazarbashi, I Maghfoor, TTweigeri, D Ajarim, A. Ezzat. Rituximab in relapsed/ refractory diffuse large B cell NHL in autologous stem cell transplant setting. 5. D.Ajarim, T Al Twegieri, M. Rahal. Multicenter prospective trial : gulf oncology research group : GORG, in locally advanced breast cancer. 6. S. Kubicka, M. Rahal.Phase III open randomized intergroup efficacy study of the combination of Bevacizumab with cross over fluoro-pyrimidine chemotherapy in patients with metastatic colorectal cancer in progression after first line chemotherapy combined with Bevacizumab. Principal Investigator for the TML ML phase III Trial
Positions held: Education/Professional Experience: Curriculum vitae
Curriculum vitae Alia Mohamed Ali Attia, M.B.B.cH., M.Sc., MD. Associate Professor of Radiation Oncology at South Egypt Cancer Institute, Assiut University, Assiut, Egypt First name: Alia Middlesbrough
Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies
Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies Nasser Alsanea, a Alaa S. Abduljabbar, a Samar Alhomoud, a Luai H. Ashari, a Denise Hibbert,
Open Trials as of end of March 2016
EORTC 10085 PRO EORTC 10085 prospective part, Clinical and biological characterization of Male Breast Cancer: an international EORTC, BIG and NABCG inter study 30 30-Jun-2016 estelle.cassoly@sakk.ch IBCSG
King Saud University Faculty of Medicine P. O. Box Riyadh, King Saud University, Riyadh, KSA
King Saud University Faculty of Medicine P. O. Box 226280 Riyadh, 11324 Kingdom of Saudi Arabia (+9661) 4699387 Office (+9661) 4671158 Fax (+966) 566066655Cell nalanazi2@ksu.edu.sa Personal Data Date of
Roche setting the standards of cancer care Oncology Event for Investors, June 19
Roche setting the standards of cancer care Oncology Event for Investors, June 19 Kapil Dhingra, VP Medical Science Developing a drug to the standard of care Superior clinical benefit, resources and time
الرياض (+966) :
10219 الرياض 11433 moghamdi@ksu.edu.sa mgksu@hotmail.com (+966) 14693611 : 2003 2010 2011 2011 2012 2011 2010 2007 2005 2010 2010 2005 2005 6 3 14 7 17 7 10 11 14 11 32 2 20050 322 2 331 1 327 422 433
NCIC CLINICAL TRIALS GROUP DATA SAFETY MONITORING COMMITTEE Friday, 1 May 2009 SUMMARY REPORT
NCIC CLINICAL TRIALS GROUP DATA SAFETY MONITORING COMMITTEE Friday, 1 May 2009 SUMMARY REPORT The NCIC CTG DSMC reviewed the following trials with respect to safety, trial conduct, including accrual, and
SUMMARY OF CURRICULUM VITAE LUIS SOUHAMI, MD
SUMMARY OF CURRICULUM VITAE LUIS SOUHAMI, MD PERSONAL INFORMATION Date of birth: February 22, 1949 Marital status: Married, 2 children Place of birth: Vitoria, Brazil Citizenship: Brazilian, Canadian WORK
CURRICULUM VITAE. Urology & Nephrology Center, Mansoura University, Mansoura, Egypt.
CURRICULUM VITAE NAME: MAHMOUD MOHAMED GABR HOME ADDRESS: 2 Othman Ben Affan Street, 6 October, Mansoura, Egypt.. PHONE: 002050 2262222 (Work). 002050 2215648 (Home). Fax: 002050 2263717 DATE OF BIRTH:
One Palliative Care Annual Report
One 203 Palliative Care Annual Report One In 202, ASCO released a provisional clinical opinion stating that concurrent palliative care should be considered early in the course of advanced or metastatic
Full Name: Raed Mohammed Fadlullah Albukhari First Father Grandfather Family Name. Marital Status: UD Employee ID: Date of Joining: 01/06/1997
Raed M. Al- Bukhari Assistant Professor Department of Internal Medicine Mobile: +966 55 570 3338 Office: +966 13 896 6741 Email: rbukhari@ud.edu.sa King Fahd Hospital of the University, P.O. Box 40034
Erbitux. Erbitux (cetuximab) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.84 Subject: Erbitux Page: 1 of 6 Last Review Date: December 2, 2016 Erbitux Description Erbitux (cetuximab)
CURRICULUM VITAE. Dr. Badr Bin Abdulrahman Al-Jandan. Shawal, 1433H (September l, 2012)
CURRICULUM VITAE Dr. Badr Bin Abdulrahman Al-Jandan College of Dentistry, University of Dammam (formally known as King Faisal University), Shawal, 1433H (September l, 2012) Personal Data Name: Badr Abdulrahman
WASHINGTON. Spokane Cheney. Olympia. Tri-Cities. Walla Walla. Portland North Central Oregon City OREGON. Mt. Vernon. Port Angeles
2 3 Mt. Vernon Port Angeles Bremerton Tacoma 5 5 Olympia Everett Edmonds Seattle 90 WASHINGTON 90 Spokane Cheney Pullman Longview 82 Tri-Cities Portland North Central Oregon City 5 84 OREGON Walla Walla
OPEN TRIALS Accruals counted until 30-April Current Accrual
Disease group Breast OPEN TRIALS Trial Title Accrual Target IBCSG 48-14 POSITIVE IBCSG 50-14 OLYMPIA IBCSG 52-15 PALLAS SAKK 21/12 A study evaluating the pregnancy outcomes and safety of interrupting endocrine
CURRICULUM VITAE. Dr. Zahid Ali Khan FORM A (1): ACADEMIC QULAIFICATIONS. Academic Degree Place of Issue Address Date. Srinager, Jammu &Kashmir
CURRICULUM VITAE Dr. Zahid Ali Khan Nationality: India Language Proficiency: English, Arabic and Urdu FORM A (1): ACADEMIC QULAIFICATIONS Academic Degree Place of Issue Address Date Bachelor Of Dental
CURRICULUM VITAE PRESENT APPOINTMENT: EDUCATION: CLINICAL TRAINING:
CURRICULUM VITAE Name : PROF. ABDULLAH AL SALLOUM Date of Birth : 1955 Nationality : Saudi Mailing Address : Department of Pediatrics (39) College of Medicine & King Khalid University Hospital P.O. Box
STUDY FINDINGS PRESENTED ON TAXOTERE REGIMENS IN HEAD AND NECK, LUNG AND BREAST CANCER
Contact: Anne Bancillon + 33 (0)6 70 93 75 28 STUDY FINDINGS PRESENTED ON TAXOTERE REGIMENS IN HEAD AND NECK, LUNG AND BREAST CANCER Key results of 42 nd annual meeting of the American Society of Clinical
Clinical Policy: Nivolumab (Opdivo) Reference Number: CP.PHAR.121
Clinical Policy: (Opdivo) Reference Number: CP.PHAR.121 Effective Date: 07/15 Last Review Date: 04/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory
Chemotherapy Treatment Algorithms for Urology Cancer
Chemotherapy Treatment Algorithms for Urology Cancer Chemoradiation for bladder cancer; Chemotherapy algorithm for non TCC bladder cancer Squamous cell carcinoma; Chemotherapy Algorithm for Non Transitional
SHORT C. V. Meletios A. Dimopoulos, MD
SHORT C. V. Meletios A. Dimopoulos, MD Meletios A. Dimopoulos, MD is Professor and Chairman of the Department of Clinical at the National and Kapodistrian, Athens, Greece. He has been elected Vice Dean
SUPPLEMENTARY INFORMATION
SUPPLEMENTARY NFORMATON n format provided by Melero et al. (AUGUST 2015) Supplementary nformation S3 Combinations including two or more immunotherapy agents based on PD-1/PD-L1 blockade. (Source: https://clinicaltrials.gov/
Are the ESMO guidelines adapted to the elderly? D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim Antwerp Belgium
Are the ESMO guidelines adapted to the elderly? D. Schrijvers, MD, PhD Ziekenhuisnetwerk Antwerpen(ZNA)-Middelheim Antwerp Belgium Clinical practice guidelines Definition > Systemically developed statements
Dr. Ahmad Maniallah Al-Thobity
CURRICULUM VITAE Dr. Ahmad Maniallah Al-Thobity Nationality: Saudi Language Proficiency: Arabic and English FORM A (): ACADEMIC QULAIFICATIONS Academic Degree Place of Issue Address Date Bachelor of Dental
TRANSPARENCY COMMITTEE OPINION. 8 November 2006
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 8 November 2006 MABTHERA 100 mg, concentrate for solution for infusion (CIP 560 600-3) Pack of 2 MABTHERA 500 mg,
Notification to Implement Issued by pcodr: December 14, 2012
PROVINCIAL FUNDING SUMMARY Bendamustine hydrochloride (Treanda) for indolent Non-Hodgkin Lymphoma and Mantle Cell Lymphoma (first-line and relapsed/refractory) perc Recommendation: Recommends For further
How to deal with patients with isolated peritoneal metastases
ESMO Preceptorship Programme Colorectal Valencia 18-19 May 2018 Michel DUCREUX, MD, PhD Gustave Roussy Cancer Centre, Grand Paris, FRANCE How to deal with patients with isolated peritoneal metastases DISCLOSURE
Lancet 2008; 372 : CDF. N Engl J Med Aug 28;349(9): J Clin Oncol May 15;19(10): Cancer Nov 1;113(9):2471-7
Tumour Group: UROLOGY Renal Palliative Sunitinib 1 st line therapy Lancet. 1999 Jan 2;353(9146):14-7. Pazopanib 1 st line therapy J Clin Oncol. 2010 28(06):1061-1068 Everolimus 2 nd or 3 rd line in adv./metas.rcc
Curriculum Vitae. B.O.Box 735 Amman Jordan. Fluent Arabic, English and Russian. Swimming, Reading, Dining and Picnics
Curriculum Vitae Albsoul, Nader Moh`d Nazzal Address B.O.Box 735 Amman 11953 Jordan Tel/Fax +962-6-5544319 Mobile +962-79-567-3425 Email Sex Marital status albsoul@yahoo.com male Married with kids D.O.B
MEDICAL PRIOR AUTHORIZATION
MEDICAL PRIOR AUTHORIZATION TAXOTERE (docetaxel) DOCEFREZ(docetaxel) docetaxel (generic) POLICY I. INDICATIONS The indications below including FDA-approved indications and compendial uses are considered
Keytruda (pembrolizumab)
Keytruda (pembrolizumab) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 10/01/2015 Current Effective Date: 07/24/2017TBD03/01/2018 POLICY A. INDICATIONS The
PRECEPTORSHIP PROGRAMME
esmo.org PRECEPTORSHIP PROGRAMME Gastrointestinal Tumours Multidisciplinary management, standards of care and future perspectives SINGAPORE 20-22 OCTOBER 2016 Co-Chairs Jean-Yves Douillard, Switzerland
Abdullah M. Alshehri. Personal Data. Language Proficiency. Academic Qualifications (Beginning with the most recent)
Abdullah M. Alshehri Assistant Professor Personal Data Nationality Saudi Date of Bir 21/08/1974 Department Internal Medicine/Cardiology Official UoD Email aalshehri@ud.edu.sa Office Phone No. +966013866666-
CancerPACT Cancer Patients Alliance for Clinical Trials
TM CancerPACT Cancer Patients Alliance for Clinical Trials Listing of Ongoing Cancer Clinical Trials in the Salinas Valley Winter 2008 I. Solid Tumors 1. Breast p.1 2. Central Nervous System p.2 3. Gastrointestinal
For Health Professionals Who Care For Cancer Patients
April 2018 Volume 21, No. 4 For Health Professionals Who Care For Cancer Patients Inside This Issue: Editor s Choice New Programs: Palbociclib for Metastatic Breast Cancer, Adjuvant Capecitabine for Breast
National Horizon Scanning Centre. Aflibercept (VEGF Trap) for advanced chemo-refractory epithelial ovarian cancer. December 2007
Aflibercept (VEGF Trap) for advanced chemo-refractory epithelial ovarian cancer December 2007 This technology summary is based on information available at the time of research and a limited literature
National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Trial design:
Open clinical uro-oncology trials in Canada Eric Winquist, MD, Mary J. Mackenzie, MD, George Rodrigues, MD London Health Sciences Centre, London, Ontario, Canada BLADDER CANCER A PHASE III STUDY OF IRESSA
FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center
FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,
C. V. Sahar Mohammed Noor Bukhary
C. V. Sahar Mohammed Noor Bukhary BDS, MSc, PhD Contact Information: Mail Address: P.O. Box 126432 Jeddah 21352, Saudi Arabia Email: sahar.bukhary@gmail.com Phone: +966 2 640-2000 ext 23216 Mobile: +966
Managing Older Patients With Lymphoma and Multiple Myeloma
2006 ONS Congress Webcast Evaluation Form Managing Older Patients With Lymphoma and Multiple Myeloma Session length: 1 hour, 45 minutes Contact hours: 1.5 Pharmacology hours offered: 15 minutes How to
17-18 October Dubai, UAE
PRELIMINARY PROGRAMME Evidence based medicine in metastatic colorectal cancer workshop 17-18 October 2014 - Dubai, UAE Dear participant, A warm welcome to all attending the Evidence based medicine in metastatic
Clinical Policy: Nivolumab (Opdivo) Reference Number: CP.PHAR.121 Effective Date: Last Review Date: Line of Business: Medicaid
Clinical Policy: (Opdivo) Reference Number: CP.PHAR.121 Effective Date: 07.15 Last Review Date: 01.18 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important
Curriculum Vitae. Home address in Saudi Arabia: Dallah Compound, Al-Nakhel, Riyadh, Kingdom of Saudi Arabia.
Curriculum Vitae Name: Karima Abd El-Hady Ahmed Zaid. Home address in Saudi Arabia: Dallah Compound, Al-Nakhel, Riyadh, Kingdom of Saudi Arabia. Phone: 0507567370 0557072878 Home address in Egypt: 2 Awad
Curriculum Vitae. Department of Anesthesiology, Shahid Beheshti University of Medical Sciences ( UMS ), Emam Hossein Hospital, Tehran, IRAN.
Dr Mehran KOUCHEK Curriculum Vitae Department of Anesthesiology, Shahid Beheshti University of Medical Sciences ( UMS ), Emam Hossein Hospital, Tehran, IRAN. Date of birth : 52 December 9121 Place of birth
Summary of Research and Writing Activities in Oncology
Summary of Research and Writing Activities in Oncology Carole Alison Chrvala, PhD 919.545.2149 (Work) 919.951.5230 (Mobile) cchrvala@centurylink.net www.healthmattersmedwriting.com 1 Manuscripts, Posters,
Open clinical uro-oncology trials in Canada
CLINICAL TRIALS Open clinical uro-oncology trials in Canada Eric Winquist, MD, Mary J. Mackenzie, MD, George Rodrigues, MD London Health Sciences Centre, London, Ontario, Canada ADRENOCORTICAL MALIGNANCIES
Chukwuemeka (Emeka) Venatius Ikpeazu, M.D., Ph.D., M.B.A., F.A.C.P. Work Phone #: Work Fax #: Citizenship: U.S.A.
DATE: September 17, 2014 I. PERSONAL Chukwuemeka (Emeka) Venatius Ikpeazu, M.D., Ph.D., M.B.A., F.A.C.P. Work Phone #: 954-210-1190 Work Fax #: 954-210-1085 Citizenship: U.S.A. Practice Address: University
Docetaxel. Class: Antineoplastic agent, Antimicrotubular, Taxane derivative.
Docetaxel Class: Antineoplastic agent, Antimicrotubular, Taxane derivative. Indications: -Breast cancer: -Non small cell lung cancer -Prostate cancer -Gastric adenocarcinoma _Head and neck cancer Unlabeled
Radiation Oncology MOC Study Guide
Radiation Oncology MOC Study Guide The following study guide is intended to give a general overview of the type of material that will be covered on the Radiation Oncology Maintenance of Certification (MOC)
Studienverzeichnis Medizinische Onkologie
Studienverzeichnis Medizinische Onkologie Mammakarzinom, Gynäkologie 21/12 24/14 25/14 96/12 PALLAS I I Transdermal CR1447 (4-OH-testosterone) in endocrine responsive-her2 negative and triple negative-androgen
Current Status of Adjuvant Therapy for Colorectal Cancer
Review Article [1] May 01, 2004 By Michael J. O connell, MD [2] Adjuvant therapy with chemotherapy and/or radiation therapy in addition to surgery improves outcome for patients with high-risk carcinomas
TRANSPARENCY COMMITTEE OPINION. 27 January 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 27 January 2010 TORISEL 25 mg/ml, concentrate for solution and diluent for solution for infusion Box containing 1
Triple Negative Breast cancer New treatment options arenowhere?
Triple Negative Breast cancer New treatment options arenowhere? Ofer Rotem, M.D., B.Sc. Breast Unit, Davidoff center Rabin Medical center October 2017 Case 6/2013 - M.D., 38 years old woman, healthy, no
Open clinical uro-oncology trials in Canada
Open clinical uro-oncology trials in Canada George Rodrigues, MD, Eric Winquist, MD, Mary J. Mackenzie, MD London Health Sciences Centre, London, Ontario, Canada ADRENOCORTICAL MALIGNANCIES CISPLATIN-BASED
DR.HANA ALHOMOUD EDUCATION PLACE OF BIRTH AND NATIONALITY: KUWAIT. LANGUAGES: Fluent in English and Arabic
DR.HANA ALHOMOUD E-mail; hana_alhomoud@hotmail.com Tel (mobile) :( +965)99227676 Tel (work): (+ 965) 24832077 PLACE OF BIRTH AND NATIONALITY: KUWAIT LANGUAGES: Fluent in English and Arabic Current Position:
OSSAMAH SALEH ABDULREHMAN AL SOWAYAN
OSSAMAH SALEH ABDULREHMAN AL SOWAYAN Assistant Professor Personal Data Nationality Saudi Date of Bir 02/09/1981 Department Urology Official UoD Email osowayan@uod.ed.sa Office Phone No. 0138966666, Ext#1690
Open clinical uro-oncology trials in Canada
Open clinical uro-oncology trials in Canada Eric Winquist, MD, Mary J. Mackenzie, MD, George Rodrigues, MD London Health Sciences Centre, London, Ontario, Canada ADRENOCORTICAL MALIGNANCIES CISPLATIN-BASED
Drug Prior Authorization Form Opdivo (nivolumab)
This document contains both information and form fields. To read information, use the Down Arrow from a form field. Drug Prior Authorization Form The purpose of this form is to obtain information required
Guidelines for the use of G-CSF in the Department of Oncology
Guidelines for the use of G-CSF in the Department of Oncology Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date
CURRICULUM VITAE. General information : Name: Alireza Nikanfar, MD.
CURRICULUM VITAE General information : Name: Alireza Nikanfar, MD. MALING ADDRESS: Tabriz University Hematology & Oncology Research Center, Shahid Ghazi Hematology & Oncology Ward, Imam Reza Hospital,
ESMO Clinical Practice Guidelines. ECCO GUIDELINES FORUM Brussels, November 27
ESMO Clinical Practice Guidelines ECCO GUIDELINES FORUM Brussels, November 27 ESMO Clinical Practice Guidelines ESMO Consensus Conferences ESMO Pocket & Mobile Guidelines ESMO Guides for Patients History
Histology independent indications in Oncology
CHMP Oncology Working Party Workshop Histology independent indications in Oncology What have we learnt from the anti PD1- PDL1 story? J Camarero (CHMP alternate ES, OncWP) Disclaimers the views presented
Vision of the Future: Capecitabine
Vision of the Future: Capecitabine CHRIS TWELVES Cancer Research Campaign Department of Medical Oncology, University of Glasgow, and Beatson Oncology Centre, Glasgow, United Kingdom Key Words. Capecitabine
CURRICULUM VITAE. Dr.Eman Kandeel
CURRICULUM VITAE Dr.Eman Kandeel Name : Eman Zaghloul Kandeel Address : ALHaram St. Al Giza, Egypt. Telephone: 002 01001543088 002 33302147 Nationality: Egyptian Date of birth: 19/12/1977 Marital status:
London Cancer New Drugs Group. February London Cancer New Drugs Group (LCNDG) Work Plan for the London Cancer Drugs Fund list.
February 2013 London Cancer New s Group (LCNDG) Work Plan for the London Cancer s Fund London Cancer s Fund List This Cancer s Fund (CDF) list of medicines and s is in two parts. 1. The standard list of
CURRICULUM VITAE. Fellow of Veterinary Surgery Urology & Nephrology Centre Mansoura University Mansoura Egypt
CURRICULUM VITAE Fellow of Veterinary Surgery Urology & Nephrology Centre Mansoura University Mansoura Egypt 1 1- PERSONAL DATA: Name : Eman Mahmoud Moussa Nour Date of Birth : 27.07.1979 Social Status
Erlotinib (Tarceva) for non small cell lung cancer advanced or metastatic maintenance monotherapy
Erlotinib (Tarceva) for non small cell lung cancer advanced or metastatic maintenance monotherapy September 2008 This technology summary is based on information available at the time of research and a
BLA /S-048, S-049, S-050, S-051, S-052, S-061, S-062, S-064, S-065, and S-066 SUPPLEMENT APPROVAL
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD 20993 BLA 125554/S-048, S-049, S-050, S-051, S-052, S-061, S-062, S-064, S-065, and S-066 SUPPLEMENT APPROVAL Bristol-Myers
When is Chemotherapy indicated in Advanced Luminal Breast Cancer?
When is Chemotherapy indicated in Advanced Luminal Breast Cancer? Soo-Chin Lee Head & Senior Consultant Department of Haematology-Oncology Clinical Care National University Cancer Institute, Singapore
Resectable locally advanced oesophagogastric cancer
Resectable locally advanced oesophagogastric cancer Clinical Case Discussion Florian Lordick University Cancer Center Leipzig University Clinic Leipzig Leipzig, Germany esmo.org DISCLOSURES Honoraria for
CURRICULUM VITAE *********
CURRICULUM VITAE ********* Name : Mahmoud M. Zakaria Hamed Ibrahim Sex : Male Date of Birth : 2 July 1969 Nationality : Egyptian Religion : Moslem Marital Status : Married + 3 Address : 9, Bank Misr St.,
National Horizon Scanning Centre. Sunitinib (Sutent) for advanced and/or metastatic breast cancer. December 2007
Sunitinib (Sutent) for advanced and/or metastatic breast cancer December 2007 This technology summary is based on information available at the time of research and a limited literature search. It is not
EPIDEMIOLOGY OF CANCER IN THE GULF REGION. Khoja, T. 1, Zahrani A. 2
EPIDEMIOLOGY OF CANCER IN THE GULF REGION Khoja, T. 1, Zahrani A. 2 (1) Council of Health Ministers for GCC State (2) Gulf Center for Gulf Registration Corresponding Author: Dr. Tawfik A. M. Khoja Family
CURRENT STANDARD OF CARE IN NASOPHARYNGEAL CANCER
CURRENT STANDARD OF CARE IN NASOPHARYNGEAL CANCER Jean-Pascal Machiels Department of medical oncology Institut I Roi Albert II Cliniques universitaires Saint-Luc Université catholique de Louvain, Brussels,
Curriculum Vitae ARUN K. KALRA, MD
Curriculum Vitae ARUN K. KALRA, MD Office: CCARE California Cancer Associates in Research and Excellence 39755 Date St. Suite 103 Murrieta, California 92563 01/2017 to current. Arun Kalra MD Inc. 09/2016
Description of Procedure or Service. Policy. Benefits Application
Corporate Medical Policy KRAS, NRAS, BRAF Mutation Analysis and Related File Name: Origination: Last CAP Review: Next CAP Review: Last Review: kras_nras_braf_mutation_analysis_and_related_treatment_in_metastatic_colorectal_cancer
Competent Pain Management for Older Patients With Cancer
Session length: 2 hours, 53 minutes Contact hours: 3.5 Pharmacology hours offered: 30 minutes 2005 ONS Virtual Institutes of Learning Evaluation Form Competent Pain Management for Older Patients With Cancer
Clinical Policy: Pemetrexed (Alimta) Reference Number: CP.PHAR.368 Effective Date: Last Review Date: Line of Business: Medicaid
Clinical Policy: (Alimta) Reference Number: CP.PHAR.368 Effective Date: 10.31.17 Last Review Date: 02.18 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end of
* In 1989 he was promoted to a job of associate professor of Neurology in Al-Azhar University.
*Dr.Fathi Mahmoud Afifi was born in Egypt. *In 1976 he started the career as a resident of Neurology and psychiatry for 2 years in Al- Azhar University Hospitals, Trained on clinical neurology, psychiatry
NOOR ALI AL-KHATHLAN
NOOR ALI AL-KHATHLAN PERSONAL INFORMATION Mobile: +966504996480 Date of birth: March 27, 1982 E- mail: Nour1402@yahoo.com Nationality: Saudi Address: House 35, 14B Street, Dammam 31434, P.O. Box 14502,
Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer
2006 ONS Congress Webcast Evaluation Form Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer Session length: 1 hour, 49 minutes Contact hours: 1.6 Pharmacology hours offered:
LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center
LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center Lymphoma is cancer of the lymphatic system. The lymphatic system is made up of organs all over the body that make up and store cells
Index. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdominal drainage, after hepatic resection, 159 160 Ablation, radiofrequency, for hepatocellular carcinoma, 160 161 Adenocarcinoma, pancreatic.
NAACR Treatment Webinar Quiz 1
NAACR Treatment Webinar Quiz 1 1. Which of the following would NOT be considered cancer-directed treatment? a. Hemicolectomy b. Incisional biopsy c. Whole breast radiation d. MRI e. All of the above f.
CURRICULUM VITAE ANWAR SHAFI, MD
CURRICULUM VITAE ANWAR SHAFI, MD Work Address Postal address Southern Illinois University School of Medicine P.O. Box l9658 Springfield, IL 62794-9658 E-Mail Address Present Position ashafi@siumed.edu
Advances in gastric cancer
ESMO Asia 2016 Industry Satellite Symposium 16 19 December 2016, Singapore Advances in gastric cancer Chair: Ian Chau With Mitsuru Sasako, Kei Muro and Yung-Jue Bang Saturday 17th December, 12:45-14:15
Systemic Cytotoxic Therapy in advanced HCC
Systemic Cytotoxic Therapy in advanced HCC Yeul Hong Kim Korea University Anam Hospital Cancer Center Hepatocellular Carcinoma : Overview Epidemiology Current Guideline : advanced HCC Cytotoxic Chemotherapy
CURRICULUM VITAE. Dammam, Saudi Arabia. Married with 3 children
CURRICULUM VITAE PERSONAL DATA NAME DR MOHAMMED H.B. KHOSHIM, FRCS[C] FACS DATE OF BIRTH 6 TH March 1954 PLACE OF BIRTH NATIONALITY MARITAL STATUS ADDRESS Dammam, Saudi Arabia Saudi Married with 3 children
NCIC CLINICAL TRIALS GROUP DATA SAFETY MONITORING COMMITTEE Fall Conference Call 23 November 2009 SUMMARY REPORT
NCIC CLINICAL TRIALS GROUP DATA SAFETY MONITORING COMMITTEE Fall Conference Call 23 November 2009 SUMMARY REPORT The NCIC CTG DSMC reviewed the following trials with respect to safety, trial conduct, including
Urogenital Malignancies Oct 15-17,2010 Constantine Algeria. President of Jordan Oncology Society Secretary General of AMAAC
Urogenital Malignancies Oct 15-17,2010 Constantine Algeria Sami Khatib, MD Consultant Clinical Oncologist President of Jordan Oncology Society Secretary General of AMAAC Amman-Jordan Mohammad Al Tarawneh,MD
Advances in chemotherapy for HER2-negative metastatic breast cancer
Review Article Page 1 of 5 Advances in chemotherapy for HER2-negative metastatic breast cancer Hirofumi Mukai, Mayuko Ito Department of Breast and Medical Oncology, National Cancer Center Hospital East,
Prof. Dr. med. Hans-Joachim Schmoll Biography
Prof. Dr. med. Hans-Joachim Schmoll Biography PubMed N publications: 445 Cumulative Impact factor: 1697 Web of Science Citation factor (h; Hirsch): 71 N Citations/year: 2017 1645 Short-CV Since 4 decades,
National Horizon Scanning Centre. Temsirolimus (Torisel) for mantle cell lymphoma - relapsed and/or refractory. January 2008
Temsirolimus (Torisel) for mantle cell lymphoma - relapsed and/or refractory January 2008 This technology summary is based on information available at the time of research and a limited literature search.
An D. Nguyen, MD Curriculum Vitae
OFFICE/ BUSINESS ADDRESS: Pacific Shores Medical Group 19582 Beach Blvd, Suite 212 Huntington Beach, CA 92648 Phone: (714) 252-9415 Fax: (714) 963-8407 ADDITIONAL OFFICE: 16300 Sand Canyon Avenue, Suite
Media Release. Roche highlights personalised medicines and cancer immunotherapies at 2016 American Society of Clinical Oncology (ASCO) Annual Meeting
Media Release Basel, 3 May 2016 Roche highlights personalised medicines and cancer immunotherapies at 2016 American Society of Clinical Oncology (ASCO) Annual Meeting 19 Roche medicines are included in
Current Position. Research activities - Publications. Athanasios Kotsakis
Athanasios Kotsakis Athanasios Kotsakis was born in Athens in 1968 and is married with 3 children. He studied Medicine at the University of Athens and continued his training in Internal Medicine at the
National Horizon Scanning Centre. Bevacizumab (Avastin) in combination with non-taxanes for metastatic breast cancer - first line therapy
Bevacizumab (Avastin) in combination with non-taxanes for metastatic breast cancer - first line therapy December 2007 This technology summary is based on information available at the time of research and
Mrs. Isabelle GAUDIN 22 years experience in Clinical Research LEAD CRA / SENIOR CLINICAL RESEARCH ASSOCIATE
Sté Aid ARC 36, Comba dels Martirs 11570 PALAJA FRANCE Fax : +33 4 68 47 03 52 Mob : +33 6 14 68 71 71 E-mail : isabelle.gaudin@aidarc.com Mrs. Isabelle GAUDIN 22 years experience in Clinical Research